$CREX
CREATIVE REALITIES, INC. Stock $crex

$crex Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000143774923031312 Filed on November 09, 2023

Income Statement

Concept	2023 Q4	2023 Q3
Revenue	$14.46M	$11.57M
YoY Change	37.83%	3.47%
Cost Of Revenue	$6.965M	$6.265M
YoY Change	19.69%	-6.02%
Gross Profit	$7.493M	$5.303M
YoY Change	60.42%	17.48%
Gross Profit Margin	51.83%	45.84%
Selling, General & Admin	$4.251M	$3.933M
YoY Change	-9.59%	12.15%
% of Gross Profit	56.73%	74.17%
Research & Development	$438.0K	$393.0K
YoY Change	23.73%	65.13%
% of Gross Profit	5.85%	7.41%
Depreciation & Amortization	$828.0K	$813.0K
YoY Change	7.12%	-8.14%
% of Gross Profit	11.05%	15.33%
Operating Expenses	$5.517M	$5.143M
YoY Change	-5.35%	7.19%
Operating Profit	$1.976M	$160.0K
YoY Change	-270.64%	-156.34%
Interest Expense	-$626.0K	$734.0K
YoY Change	663.41%	-3.04%
% of Operating Profit	-31.68%	458.75%
Other Income/Expense, Net	$79.00K	-$2.106M
YoY Change	-1228.57%	652.14%
Pretax Income	$1.429M	-$1.946M
YoY Change	-209.84%	245.04%
Income Tax	$10.00K	-$15.00K
% Of Pretax Income	0.7%
Net Earnings	$1.419M	-$1.931M
YoY Change	-206.37%	248.56%
Net Earnings / Revenue	9.81%	-16.69%
Basic Earnings Per Share		-$0.22
Diluted Earnings Per Share	$0.13	-$0.22
COMMON SHARES
Basic Shares Outstanding	10.41M	7.409M
Diluted Shares Outstanding		8.713M

Balance Sheet

Concept	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.910M	$8.376M
YoY Change	78.2%	922.71%
Cash & Equivalents	$2.910M	$8.376M
Short-Term Investments
Other Short-Term Assets	$665.0K	$960.0K
YoY Change	-63.44%	-40.67%
Inventory	$2.567M	$2.306M
Prepaid Expenses
Receivables	$12.47M	$5.865M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$18.61M	$17.51M
YoY Change	33.1%	35.19%
LONG-TERM ASSETS
Property, Plant & Equipment	$499.0K	$513.0K
YoY Change	148.26%	165.8%
Goodwill	$26.45M	$26.45M
YoY Change	0.0%	1.38%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$112.0K	$43.00K
YoY Change	160.47%	126.32%
Total Long-Term Assets	$52.17M	$52.18M
YoY Change	0.26%	0.81%
TOTAL ASSETS
Total Short-Term Assets	$18.61M	$17.51M
Total Long-Term Assets	$52.17M	$52.18M
Total Assets	$70.78M	$69.69M
YoY Change	7.21%	7.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.876M	$3.340M
YoY Change	109.64%	9.87%
Accrued Expenses	$3.761M	$4.499M
YoY Change	-1.75%	48.53%
Deferred Revenue	$1.132M	$3.507M
YoY Change	-7.44%
Short-Term Debt	$0.00	$0.00
YoY Change		-100.0%
Long-Term Debt Due	$3.690M	$4.211M
YoY Change	-17.98%	136.97%
Total Short-Term Liabilities	$20.20M	$19.66M
YoY Change	22.44%	46.34%
LONG-TERM LIABILITIES
Long-Term Debt	$9.829M	$10.57M
YoY Change	-24.81%	-20.81%
Other Long-Term Liabilities	$176.0K	$175.0K
YoY Change	-14.15%	-98.48%
Total Long-Term Liabilities	$10.01M	$10.75M
YoY Change	-24.65%	-56.79%
TOTAL LIABILITIES
Total Short-Term Liabilities	$20.20M	$19.66M
Total Long-Term Liabilities	$10.01M	$10.75M
Total Liabilities	$41.95M	$42.29M
YoY Change	3.73%	10.38%
SHAREHOLDERS EQUITY
Retained Earnings	-$53.35M	-$54.77M
YoY Change	5.83%	11.59%
Common Stock	$104.0K	$104.0K
YoY Change	-52.29%	-52.07%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$28.83M	$27.40M
YoY Change
Total Liabilities & Shareholders Equity	$70.78M	$69.69M
YoY Change	7.21%	7.69%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	$1.419M	-$1.931M
YoY Change	-206.37%	248.56%
Depreciation, Depletion And Amortization	$828.0K	$813.0K
YoY Change	7.12%	-8.14%
Cash From Operating Activities	-$3.139M	$1.966M
YoY Change	-1017.84%	-299.19%
INVESTING ACTIVITIES
Capital Expenditures	$889.0K	$938.0K
YoY Change	-26.35%	-229.92%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00
YoY Change
Cash From Investing Activities	-$889.0K	-$938.0K
YoY Change	-26.35%	29.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.438M	4.085M
YoY Change	-185.65%	-1409.29%
NET CHANGE
Cash From Operating Activities	-3.139M	1.966M
Cash From Investing Activities	-889.0K	-938.0K
Cash From Financing Activities	-1.438M	4.085M
Net Change In Cash	-5.466M	5.113M
YoY Change	-771.5%	-352.99%
FREE CASH FLOW
Cash From Operating Activities	-$3.139M	$1.966M
Capital Expenditures	$889.0K	$938.0K
Free Cash Flow	-$4.028M	$1.028M
YoY Change	365.66%	-487.92%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	66666000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	66666000
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10409000
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10409000
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7266000
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7266000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-33169
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MN
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	41-1967918
	dei	Entity Address Address Line1 EntityAddressAddressLine1	13100 Magisterial Drive, Suite 100
	dei	Entity Address City Or Town EntityAddressCityOrTown	Louisville
	dei	Entity Address State Or Province EntityAddressStateOrProvince	KY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	40223
	dei	City Area Code CityAreaCode	502
	dei	Local Phone Number LocalPhoneNumber	791-8800
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	75916000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-54765000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-50409000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	27403000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	25579000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	69689000	usd
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10409027
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8376000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1633000	usd
CY2023Q3	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	5865000	usd
CY2022Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	8263000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	2306000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	2267000	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	960000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1819000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	17507000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	13982000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	513000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	201000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1198000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1584000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	23975000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	23752000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	26453000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	26453000	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	43000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	43000	usd
CY2023Q3	us-gaap	Assets Assets	69689000	usd
CY2022Q4	us-gaap	Assets Assets	66015000	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	3340000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3757000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4499000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3828000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3507000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1223000	usd
CY2023Q3	crex	Customer Deposit Current CustomerDepositCurrent	3532000	usd
CY2022Q4	crex	Customer Deposit Current CustomerDepositCurrent	2478000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	575000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	711000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	19664000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	16496000	usd
CY2023Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	0	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	208000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	623000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	873000	usd
CY2023Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	11250000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	9789000	usd
CY2023Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	175000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	205000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	42286000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	40436000	usd
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	104000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	72000	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	82064000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	66015000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	11568000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	11180000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	30708000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	32860000	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6265000	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6666000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	16018000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	19792000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	5303000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	4514000	usd
	us-gaap	Gross Profit GrossProfit	14690000	usd
	us-gaap	Gross Profit GrossProfit	13068000	usd
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1301000	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	718000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3666000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2572000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	393000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	238000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1136000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	897000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2632000	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2847000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8125000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8269000	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	817000	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	885000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2393000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2060000	usd
CY2023Q3	crex	Deal And Transaction Costs DealAndTransactionCosts	0	usd
CY2022Q3	crex	Deal And Transaction Costs DealAndTransactionCosts	110000	usd
	crex	Deal And Transaction Costs DealAndTransactionCosts	0	usd
	crex	Deal And Transaction Costs DealAndTransactionCosts	538000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	5143000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	4798000	usd
	us-gaap	Operating Expenses OperatingExpenses	15320000	usd
	us-gaap	Operating Expenses OperatingExpenses	14336000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	160000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-284000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-630000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1268000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	734000	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	757000	usd
	us-gaap	Interest Expense InterestExpense	2324000	usd
	us-gaap	Interest Expense InterestExpense	1956000	usd
CY2023Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1369000	usd
CY2022Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-442000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1461000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-369000	usd
CY2023Q3	crex	Loss On Warrant Amendment LossOnWarrantAmendment	-0	usd
CY2022Q3	crex	Loss On Warrant Amendment LossOnWarrantAmendment	-0	usd
	crex	Loss On Warrant Amendment LossOnWarrantAmendment	-0	usd
	crex	Loss On Warrant Amendment LossOnWarrantAmendment	345000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1461000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-369000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	44000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2080000	usd
CY2023Q3	crex	Gain Loss On Settlement Of Debt GainLossOnSettlementOfDebt	0	usd
CY2022Q3	crex	Gain Loss On Settlement Of Debt GainLossOnSettlementOfDebt	37000	usd
	crex	Gain Loss On Settlement Of Debt GainLossOnSettlementOfDebt	0	usd
	crex	Gain Loss On Settlement Of Debt GainLossOnSettlementOfDebt	-237000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	132000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2106000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-280000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3653000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4524000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1946000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-564000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4283000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3256000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-15000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-10000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	73000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	46000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1931000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-554000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4356000	usd
	us-gaap	Net Income Loss NetIncomeLoss	3210000	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.56
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.5
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.56
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.5
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8713000
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7250000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7775000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6461000
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8713000
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7250000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7775000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6461000
	us-gaap	Net Income Loss NetIncomeLoss	-4356000	usd
	us-gaap	Net Income Loss NetIncomeLoss	3210000	usd
	crex	Depreciation Depletion And Amortization Excluding Amortization Of Debt Discount Premium DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtDiscountPremium	2393000	usd
	crex	Depreciation Depletion And Amortization Excluding Amortization Of Debt Discount Premium DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtDiscountPremium	2060000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1078000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	904000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	539000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1587000	usd
	crex	Loss On Warrant Amendment LossOnWarrantAmendment	0	usd
	crex	Loss On Warrant Amendment LossOnWarrantAmendment	345000	usd
	crex	Gain Loss On Settlement Of Debt GainLossOnSettlementOfDebt	-0	usd
	crex	Gain Loss On Settlement Of Debt GainLossOnSettlementOfDebt	-237000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	318000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	105000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2835000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	39000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1032000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-859000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-682000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-53000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-227000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	683000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	533000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	2284000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1019000	usd
	crex	Increase Decrease In Customer Deposit IncreaseDecreaseInCustomerDeposit	1054000	usd
	crex	Increase Decrease In Customer Deposit IncreaseDecreaseInCustomerDeposit	-585000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	39000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-6000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	8306000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1050000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-0	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	17186000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	287000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	123000	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	2851000	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	2959000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3138000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-20268000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	14000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	-0	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5454000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	1814000	usd
	crex	Proceeds From Warrant Issuance And Exercises ProceedsFromWarrantIssuanceAndExercises	0	usd
	crex	Proceeds From Warrant Issuance And Exercises ProceedsFromWarrantIssuanceAndExercises	8295000	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	9868000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1575000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	19254000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	6743000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2064000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1633000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2883000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8376000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	819000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	23858000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5454000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1931000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	27403000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	25579000	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	139000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5454000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4356000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	27403000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	26437000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-554000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	26402000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	8729000	usd
	crex	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	2278000	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	5000000	usd
	crex	Adjustments To Additional Paid In Capital Warrant Repricing AdjustmentsToAdditionalPaidInCapitalWarrantRepricing	0	usd
	crex	Adjustments To Additional Paid In Capital Amendment Of Warrants AdjustmentsToAdditionalPaidInCapitalAmendmentOfWarrants	5709000	usd
	us-gaap	Net Income Loss NetIncomeLoss	3210000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	26402000	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	66666666
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-54765000	usd
CY2023Q3	crex	Working Capital WorkingCapital	2157000	usd
CY2023Q3	us-gaap	Debt Current DebtCurrent	4211000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8376000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-630000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	8306000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	984000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	318000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	228000	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1074000	usd
CY2023Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1745000	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1671000	usd
CY2023Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	561000	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	596000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	2306000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	2267000	usd
CY2023Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	192000	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1777000	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7391651
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7490962
CY2023Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i><em style="font: inherit;">10.</em> Use of Estimates</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Our significant estimates include: contingent purchase consideration valuation, allowance for credit losses, valuation allowances related to deferred taxes, the fair value of acquired assets and liabilities, the fair value of liabilities reliant upon the appraised fair value of the Company, valuation of stock-based compensation awards and other assumptions and estimates used to evaluate the recoverability of long-lived assets, goodwill and other intangible assets and the related amortization methods and periods. Actual results could differ from those estimates.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"></p>
CY2023Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	11568000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	11180000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	30708000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	32860000	usd
CY2021Q4	crex	Business Combination Contingent Consideration Billable Devices Online Maximum Share Price BusinessCombinationContingentConsiderationBillableDevicesOnlineMaximumSharePrice	21.6
CY2022Q4	crex	Business Combination Contingent Consideration Billable Devices Online Maximum Share Price BusinessCombinationContingentConsiderationBillableDevicesOnlineMaximumSharePrice	19.2
CY2022Q4	crex	Business Combination Contingent Consideration Billable Devices Online Reduction In Share Price BusinessCombinationContingentConsiderationBillableDevicesOnlineReductionInSharePrice	2.4
	crex	Capitalized Software In Accounts Payable CapitalizedSoftwareInAccountsPayable	211000	usd
	crex	Capitalized Software In Accounts Payable CapitalizedSoftwareInAccountsPayable	998000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	154000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
	crex	Conversion Of Liability Warrants To Equity Warrants ConversionOfLiabilityWarrantsToEquityWarrants	0	usd
	crex	Conversion Of Liability Warrants To Equity Warrants ConversionOfLiabilityWarrantsToEquityWarrants	5709000	usd
	us-gaap	Interest Paid Net InterestPaidNet	1303000	usd
	us-gaap	Interest Paid Net InterestPaidNet	835000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	566000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	256000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	48000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	19000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	37648000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	13673000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	35151000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	11399000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	13673000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	11399000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	23975000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	23752000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	766000	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	848000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2274000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1959000	usd
CY2023Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	16777000	usd
	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	1731499
CY2023Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1992000	usd
CY2023Q3	us-gaap	Long Term Debt LongTermDebt	14785000	usd
CY2023Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	4211000	usd
CY2023Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	10574000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	20641000	usd
CY2022	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	1731499
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	3069000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	17572000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	4499000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	13073000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-15000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	73000	usd
CY2023Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	72000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	28000	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y3M10D
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	0	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	55000	usd
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	30000	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	100000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001437749-23-031312-index-headers.html	Edgar Link	pending
0001437749-23-031312-index.html	Edgar Link	pending
0001437749-23-031312.txt	Edgar Link	pending
0001437749-23-031312-xbrl.zip	Edgar Link	pending
crex-20230930.xsd	Edgar Link	pending
crex20230815_10q.htm	Edgar Link	pending
crexlogonew.jpg	Edgar Link	pending
ex_561190.htm	Edgar Link	pending
ex_561191.htm	Edgar Link	pending
ex_561192.htm	Edgar Link	pending
ex_561193.htm	Edgar Link	pending
ex_561194.htm	Edgar Link	pending
crex-20230930_cal.xml	Edgar Link	unprocessable
crex-20230930_def.xml	Edgar Link	unprocessable
crex-20230930_lab.xml	Edgar Link	unprocessable
crex-20230930_pre.xml	Edgar Link	unprocessable
crex20230815_10q_htm.xml	Edgar Link	completed
ex_594437.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CREX
CREATIVE REALITIES, INC. Stock $crex

2023 Q4 Form 10-Q Financial Statement

#000143774923031312 Filed on November 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CREX CREATIVE REALITIES, INC. Stock $crex

2023 Q4 Form 10-Q Financial Statement

#000143774923031312 Filed on November 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CREX
CREATIVE REALITIES, INC. Stock $crex